- Home
- XPEV vs TEVA Comparison
XPEV vs TEVA Comparison
Compare XPEV & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEV
- TEVA
- Stock Information
- Founded
- XPEV 2015
- TEVA 1901
- Country
- XPEV China
- TEVA Israel
- Employees
- XPEV N/A
- TEVA N/A
- Industry
- XPEV Auto Manufacturing
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- XPEV Consumer Discretionary
- TEVA Health Care
- Exchange
- XPEV Nasdaq
- TEVA Nasdaq
- Market Cap
- XPEV 21.7B
- TEVA 21.2B
- IPO Year
- XPEV 2020
- TEVA N/A
- Fundamental
- Price
- XPEV $21.19
- TEVA $19.32
- Analyst Decision
- XPEV Buy
- TEVA Strong Buy
- Analyst Count
- XPEV 8
- TEVA 7
- Target Price
- XPEV $22.51
- TEVA $25.57
- AVG Volume (30 Days)
- XPEV 7.7M
- TEVA 10.0M
- Earning Date
- XPEV 11-18-2025
- TEVA 11-05-2025
- Dividend Yield
- XPEV N/A
- TEVA N/A
- EPS Growth
- XPEV N/A
- TEVA N/A
- EPS
- XPEV N/A
- TEVA N/A
- Revenue
- XPEV $8,416,181,216.00
- TEVA $16,628,000,000.00
- Revenue This Year
- XPEV $99.57
- TEVA $4.37
- Revenue Next Year
- XPEV $39.79
- TEVA $0.67
- P/E Ratio
- XPEV N/A
- TEVA N/A
- Revenue Growth
- XPEV 66.37
- TEVA 2.08
- 52 Week Low
- XPEV $10.07
- TEVA $12.47
- 52 Week High
- XPEV $27.16
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- XPEV 44.34
- TEVA 48.21
- Support Level
- XPEV $20.81
- TEVA $19.68
- Resistance Level
- XPEV $22.13
- TEVA $20.10
- Average True Range (ATR)
- XPEV 0.81
- TEVA 0.55
- MACD
- XPEV -0.29
- TEVA -0.10
- Stochastic Oscillator
- XPEV 11.94
- TEVA 14.94
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 190,000 EVs in 2024, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.